Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

New Recipe For Asymmetric Allenes

Chemists design a general route for making complex tetrasubstituted dienes to serve as synthetic intermediates in drug discovery

by Stephen K. Ritter
February 25, 2013 | A version of this story appeared in Volume 91, Issue 8

When it comes to making complex organic molecules in the drug discovery process, a catalytic route to the asymmetric allene class of compounds has been elusive. A research team led by Keiji Maruoka of Kyoto University, in Japan, now reports a strategy to resolve this shortcoming (Nat. Chem., DOI: 10.1038/nchem.1567). Allenes feature two consecutive double bonds in a carbon chain. This unusual pattern opens up the possibility of placing different substituent groups at each position on the terminal carbon atoms of the allene group, creating asymmetric molecules with useful biological activity. To make these allenes, Maruoka and colleagues used ammonium salts containing binaphthyl groups as chiral catalysts to generate enolate-type intermediates from alkylallene dicarboxylates. By treating the intermediates with imine electrophiles, the researchers prepared tetrasubstituted allenes containing a chiral amine group. When they used alkyl halides as the electrophile, they made tetra­sub­stituted alkylallenes (shown) or alkynes, depending on the starting allene and the choice of catalyst. The Kyoto researchers further showed that the new asymmetric allenes can easily undergo ring-closing reactions to form densely substituted pyrroles and furanones, which are desirable drug candidates.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.